secwatch.observer — SEC 8-K summary
======================================

Issuer:     Axsome Therapeutics, Inc. (AXSM)
CIK:        0001579428
Form:       8-K
Filed at:   2023-10-11T23:59:59+00:00
Accession:  0000950170-23-052940
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Axsome Therapeutics appoints Dr. Susan Mahony to board of directors
-------------------------------------------------------------------

- Board expanded from 4 to 5 directors; Dr. Mahony appointed effective Oct. 10, 2023.
- Former Horizon Therapeutics board member and ex-SVP/President of Lilly Oncology.
- Received initial option grant worth $325,000 vesting over 3 years and a pro-rated grant of $81,250 vesting in 1 year.
- Annual cash retainer for non-employee directors, pro-rated for 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1579428/000095017023052940/0000950170-23-052940-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1579428/000095017023052940/axsm-20231008.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-052940

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer